Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1986 Nov 1;239(3):531–536. doi: 10.1042/bj2390531

Hormonal control of fructose 2,6-bisphosphate concentration in the HT29 human colon adenocarcinoma cell line. Alpha 2-adrenergic agonists counteract effect of vasoactive intestinal peptide.

C Denis, H Paris, J C Murat
PMCID: PMC1147319  PMID: 3030263

Abstract

Vasoactive intestinal peptide (VIP) was found to cause a dose-dependent decrease in fructose 2,6-bisphosphatase concomitant with an increase in cyclic AMP in cultured HT29 cancer cells from human colon. The maximum effect was a 41% decrease obtained with 10 nM-VIP, and half-maximum effect was obtained with 0.75 nM-VIP. The effect of 2.5 nM-VIP was almost totally counteracted (i.e. fructose 2,6-bisphosphate concentration was restored) by either adrenaline (1 microM) or the alpha 2-adrenergic agonist UK-14304 (1 microM); the alpha 2-agonist clonidine (1 microM) was less efficient, since the VIP effect was decreased by 72% only. The adrenaline effect was totally antagonized by 1 microM-yohimbine. It is concluded that, in the HT29 cancer cells, the fructose 2,6-bisphosphate-producing system is sensitive to variations of cyclic AMP concentration and is under the dual control of VIP and alpha 2-adrenergic receptors.

Full text

PDF
531

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ardawi M. S., Newsholme E. A. Fuel utilization in colonocytes of the rat. Biochem J. 1985 Nov 1;231(3):713–719. doi: 10.1042/bj2310713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bartrons R., Hue L., Van Schaftingen E., Hers H. G. Hormonal control of fructose 2,6-bisphosphate concentration in isolated rat hepatocytes. Biochem J. 1983 Sep 15;214(3):829–837. doi: 10.1042/bj2140829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Boige N., Munck A., Laburthe M. Adrenergic versus VIPergic control of cyclic AMP in human colonic crypts. Peptides. 1984 Mar-Apr;5(2):379–383. doi: 10.1016/0196-9781(84)90238-9. [DOI] [PubMed] [Google Scholar]
  4. Bouscarel B., Cortinovis C., Carpene C., Murat J. C., Paris H. alpha 2-Adrenoceptors in the HT 29 human colon adenocarcinoma cell line: characterization with [3H]clonidine; effects on cyclic AMP accumulation. Eur J Pharmacol. 1985 Jan 2;107(2):223–231. doi: 10.1016/0014-2999(85)90062-7. [DOI] [PubMed] [Google Scholar]
  5. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1006/abio.1976.9999. [DOI] [PubMed] [Google Scholar]
  6. Carpene C., Paris H., Cortinovis C., Viallard V., Murat J. C. Characterization of alpha 2-adrenergic receptors in the human colon adenocarcinoma cell line HT 29 in culture by [3H]yohimbine binding. Gen Pharmacol. 1983;14(6):701–703. doi: 10.1016/0306-3623(83)90173-8. [DOI] [PubMed] [Google Scholar]
  7. Denis C., Cortinovis C., Terrain B., Viallard V., Paris H., Murat J. C. Activity of enzymes related to carbohydrate metabolism in the HT 29 colon adenocarcinoma cell line and tumor. Int J Biochem. 1984;16(1):87–91. doi: 10.1016/0020-711x(84)90055-7. [DOI] [PubMed] [Google Scholar]
  8. Fogh J., Fogh J. M., Orfeo T. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst. 1977 Jul;59(1):221–226. doi: 10.1093/jnci/59.1.221. [DOI] [PubMed] [Google Scholar]
  9. Hers H. G., Hue L. Gluconeogenesis and related aspects of glycolysis. Annu Rev Biochem. 1983;52:617–653. doi: 10.1146/annurev.bi.52.070183.003153. [DOI] [PubMed] [Google Scholar]
  10. Hue L., Blackmore P. F., Exton J. H. Fructose 2,6-bisphosphate. Hormonal regulation and mechanism of its formation in liver. J Biol Chem. 1981 Sep 10;256(17):8900–8903. [PubMed] [Google Scholar]
  11. Hue L., Sobrino F., Bosca L. Difference in glucose sensitivity of liver glycolysis and glycogen synthesis. Relationship between lactate production and fructose 2,6-bisphosphate concentration. Biochem J. 1984 Dec 15;224(3):779–786. doi: 10.1042/bj2240779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Laburthe M., Amiranoff B., Boissard C. Alpha-Adrenergic inhibition of cyclic AMP accumulation in epithelial cells isolated from rat small intestine. Biochim Biophys Acta. 1982 Sep 13;721(1):101–108. doi: 10.1016/0167-4889(82)90029-5. [DOI] [PubMed] [Google Scholar]
  13. Laburthe M., Rousset M., Boissard C., Chevalier G., Zweibaum A., Rosselin G. Vasoactive intestinal peptide: a potent stimulator of adenosine 3':5'-cyclic monophosphate accumulation in gut carcinoma cell lines in culture. Proc Natl Acad Sci U S A. 1978 Jun;75(6):2772–2775. doi: 10.1073/pnas.75.6.2772. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Loiseau A. M., Rousseau G. G., Hue L. Fructose 2,6-bisphosphate and the control of glycolysis by glucocorticoids and by other agents in rat hepatoma cells. Cancer Res. 1985 Sep;45(9):4263–4269. [PubMed] [Google Scholar]
  15. Marvaldi J., Mangeat P., Ahmed O. A., Coeroli C., Marchis-Mouren G. Activation of cyclic AMP-dependent protein kinases in human gut adenocarcinoma (HT 29) cells in culture. Biochim Biophys Acta. 1979 Nov 15;588(1):12–19. doi: 10.1016/0304-4165(79)90365-9. [DOI] [PubMed] [Google Scholar]
  16. McGrane M. M., El-Maghrabi M. R., Pilkis S. J. The interaction of fructose 2,6-bisphosphate and AMP with rat hepatic fructose 1,6-bisphosphatase. J Biol Chem. 1983 Sep 10;258(17):10445–10454. [PubMed] [Google Scholar]
  17. McMahon K. K., Schimmel R. J. Evidence for alpha-adrenergic activation and inactivation of phosphorylase in hamster adipocytes. Mol Pharmacol. 1981 Sep;20(2):339–344. [PubMed] [Google Scholar]
  18. Nakaki T., Nakadate T., Yamamoto S., Kato R. Alpha 2-adrenergic receptor in intestinal epithelial cells. Identification by [3H]yohimbine and failure to inhibit cyclic AMP accumulation. Mol Pharmacol. 1983 Jan;23(1):228–234. [PubMed] [Google Scholar]
  19. Paris H., Bouscarel B., Cortinovis C., Murat J. C. Growth-related variation of alpha 2-adrenergic receptivity in the HT 29 adenocarcinoma cell-line from human colon. FEBS Lett. 1985 May 6;184(1):82–86. doi: 10.1016/0014-5793(85)80658-x. [DOI] [PubMed] [Google Scholar]
  20. Pilkis S. J., Chrisman T. D., El-Maghrabi M. R., Colosia A., Fox E., Pilkis J., Claus T. H. The action of insulin on hepatic fructose 2,6-bisphosphate metabolism. J Biol Chem. 1983 Feb 10;258(3):1495–1503. [PubMed] [Google Scholar]
  21. Pilkis S. J., El-Maghrabi M. R., Pilkis J., Claus T. Inhibition of fructose-1,6-bisphosphatase by fructose 2,6-bisphosphate. J Biol Chem. 1981 Apr 25;256(8):3619–3622. [PubMed] [Google Scholar]
  22. Rider M. H., Hue L. Regulation of fructose 2,6-bisphosphate concentration in white adipose tissue. Biochem J. 1985 Jan 15;225(2):421–428. doi: 10.1042/bj2250421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Rousset M., Laburthe M., Chevalier G., Boissard C., Rosselin G., Zweibaum A. Vasoactive intestinal peptide (VIP) control of glycogenolysis in the human colon carcinoma cell line HT-29 in culture. FEBS Lett. 1981 Apr 6;126(1):38–40. doi: 10.1016/0014-5793(81)81027-7. [DOI] [PubMed] [Google Scholar]
  24. Rousset M., Paris H., Chevalier G., Terrain B., Murat J. C., Zweibaum A. Growth-related enzymatic control of glycogen metabolism in cultured human tumor cells. Cancer Res. 1984 Jan;44(1):154–160. [PubMed] [Google Scholar]
  25. Sener A., Van Schaftingen E., Van de Winkel M., Pipeleers D. G., Malaisse-Lagae F., Malaisse W. J., Hers H. G. Effects of glucose and glucagon on the fructose 2,6-bisphosphate content of pancreatic islets and purified pancreatic B-cells. A comparison with isolated hepatocytes. Biochem J. 1984 Aug 1;221(3):759–764. doi: 10.1042/bj2210759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Sobrino F., Gualberto A. Hormonal regulation of fructose 2,6-bisphosphate levels in epididymal adipose tissue of rat. FEBS Lett. 1985 Mar 25;182(2):327–330. doi: 10.1016/0014-5793(85)80326-4. [DOI] [PubMed] [Google Scholar]
  27. Steiner A. L., Parker C. W., Kipnis D. M. Radioimmunoassay for cyclic nucleotides. I. Preparation of antibodies and iodinated cyclic nucleotides. J Biol Chem. 1972 Feb 25;247(4):1106–1113. [PubMed] [Google Scholar]
  28. Turner J. T., Ray-Prenger C., Bylund D. B. Alpha 2-adrenergic receptors in the human cell line, HT29. Characterization with the full agonist radioligand [3H]UK-14,304 and inhibition of adenylate cyclase. Mol Pharmacol. 1985 Nov;28(5):422–430. [PubMed] [Google Scholar]
  29. Van Schaftingen E., Hue L., Hers H. G. Fructose 2,6-bisphosphate, the probably structure of the glucose- and glucagon-sensitive stimulator of phosphofructokinase. Biochem J. 1980 Dec 15;192(3):897–901. doi: 10.1042/bj1920897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Van Schaftingen E., Lederer B., Bartrons R., Hers H. G. A kinetic study of pyrophosphate: fructose-6-phosphate phosphotransferase from potato tubers. Application to a microassay of fructose 2,6-bisphosphate. Eur J Biochem. 1982 Dec;129(1):191–195. doi: 10.1111/j.1432-1033.1982.tb07039.x. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES